Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endosmart is a German medical device company focused on the design, development, and manufacture of nitinol-based medical components, instruments, and implants for minimally invasive procedures. Its product portfolio has included kidney stone retrieval baskets and snares, breast cancer tumor markers, and other surgical instruments for urology, oncology, cardiology, orthopedic, and vascular applications. The company also provides OEM and contract development/manufacturing services for medical device customers, leveraging expertise in nitinol forming, joining, and product engineering. Endosmart was acquired by Alleima in 2022 and, effective February 1, 2024, was renamed Alleima Karlsruhe GmbH while continuing operations within Alleima's medical business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endosmart.